Skip to main content

Maria Cristina Díaz de Heredia Rubio

I am a pediatrician specialized in pediatric hematology and oncology and in hematopoietic stem cell transplantation. My clinical and research activity focuses on blood disorders, leukemias, and other non-oncological hematological diseases, as well as on hematopoietic stem cell transplantation in children. Since 2005, I am the Head of the Pediatric Hematology Section and I lead the Hematopoietic Stem Cell Transplantation and Advanced Therapies Program within the Department of Pediatric Oncology and Hematology. I am committed to bringing the most innovative treatments to our patients. At the national level, I lead the pediatric group of the Spanish Group for Hematopoietic Transplantation (GETH) and the hematopoietic stem cell transplantation group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP), with the aim of improving the clinical outcomes of this procedure in children and adolescents. I am an active member of the board of the European pediatric hematopoietic stem cell transplantation group of the European Society for Blood and Marrow Transplantation (EBMT), and I actively participate in the SEHOP bone marrow failure working group. My commitment and dedication to hematopoietic stem cell transplantation and bone marrow failure syndromes have made me a national reference in these fields.

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Head of Section
Paediatric Oncology and Haematology
Children's Hospital and Woman's Hospital

Maria Cristina Díaz de Heredia Rubio

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Head of Section
Paediatric Oncology and Haematology
Children's Hospital and Woman's Hospital

I am a pediatrician specialized in pediatric hematology and oncology and in hematopoietic stem cell transplantation. My clinical and research activity focuses on blood disorders, leukemias, and other non-oncological hematological diseases, as well as on hematopoietic stem cell transplantation in children. Since 2005, I am the Head of the Pediatric Hematology Section and I lead the Hematopoietic Stem Cell Transplantation and Advanced Therapies Program within the Department of Pediatric Oncology and Hematology. I am committed to bringing the most innovative treatments to our patients. At the national level, I lead the pediatric group of the Spanish Group for Hematopoietic Transplantation (GETH) and the hematopoietic stem cell transplantation group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP), with the aim of improving the clinical outcomes of this procedure in children and adolescents. I am an active member of the board of the European pediatric hematopoietic stem cell transplantation group of the European Society for Blood and Marrow Transplantation (EBMT), and I actively participate in the SEHOP bone marrow failure working group. My commitment and dedication to hematopoietic stem cell transplantation and bone marrow failure syndromes have made me a national reference in these fields.

In terms of research, I am a member of the “Childhood Cancer and Blood Disorders” group at the Vall d’Hebron Research Institute (VHIR) and I lead the Hematopoietic Stem Cell Transplantation and Advanced Therapies Program within this group. I am the national coordinator of the international clinical trial ALL-SCT FORUM, with the objective to identify the optimal transplantation strategy in children and adolescents with acute lymphoblastic leukemia. In the field of advanced cellular therapies, I work on several innovative projects in gene therapy for congenital diseases, as well as on the use of mesenchymal cells and antigen-specific cytotoxic lymphocytes for the treatment of certain post-transplant complications.

Projects

RTICC - Red Temática de Investigación cooperativa de cáncer

IP: Josep Sánchez de Toledo Codina
Collaborators: Soledad Gallego Melcón, Luís Gros Subias, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Constantino Sábado Álvarez, Anna Llort Sales, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 51990
Reference: RD06/0020/1021
Duration: 01/01/2008 - 31/12/2014

Related news

The integration of Patient-Reported Outcome Measures (PROMs) will make it possible to incorporate patients' experiences and quality of life into research on sickle cell disease and other rare anaemias.

The Scientific Coordinator of ERN-EuroBloodNet will lead for one year the group that defines the common strategy of the European Reference Networks to improve care for rare and complex diseases.

Vall d’Hebron participates as a reference centre in Spain for early-phase clinical trials and coordinates the national ReALLNet network, promoting research into relapsed acute lymphoblastic leukemia.

Related professionals

Alba González Robles

Alba González Robles

Predoctoral researcher
Infectious Diseases
Read more
Maria Martinez Pla

Maria Martinez Pla

Main researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Silvia Enriquez Calzada

Silvia Enriquez Calzada

Predoctoral researcher
Neurodegenerative Diseases
Read more
Raquel Villegas Pastor

Raquel Villegas Pastor

Tècnic de recerca
Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.